Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


International Bioprinting Congress

24 Jul 2014 - 25 Jul 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is pleased to present the inaugural International Bioprinting Congress, which will take place at the Biopolis, Singapore.

The event will present the leading international scientists and thought leaders within this rapidly developing field. Featuring Professor Chua Chee Kai, Chair, School of Mechanical and Aerospace Engineering, Nanyang Technological University and Director Nanyang Additive Manufacturing Centre, Singapore and Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan as our conference chairs. This event will provide you with a detailed insight into the latest developments and techniques in 3D bioprinting.

During this conference, you will learn about the many advances in 3D bioprinting covering; Additive Manufacturing of Tissues and Biofabrication, Scaffolds and Biomaterials for Tissue Engineering, Biological Laser Printing, Biological Inkjet Printing, Search for the Synergy by Fusion of Bio-Additive Manufacturing and Micro Manufacturing, Cell and Tissue Patterning for Lab-on-a-Chip and Tissue Models plus Additive Manufacturing and Medical Devices.
Scientific presentations will be followed by panel discussions on the day’s topics, providing
a balanced overview of the industry from the varied perspectives of the leading researchers, investors and legislative authorities.

Scientific presentations will be followed by panel discussions on the day’s topics, providing
a balanced overview of the industry from the varied perspectives of the leading researchers, investors and legislative authorities.

A tour of the facilities at the Nanyang Technological University Additive Manufacturing Centre will also be offered. The tour is open to all conference attendees and will take place on Thursday 24th July, with coach transfers leaving the Biopolis at 16:00.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations.



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!